Skip to main content

News

10 May, 2016 Asif Khowaja Best Student Poster Winner at 2016 CADITH Symposium
Photo credit: The Canadian Agency for Drugs and Technology in Healthcare (CADTH) Asif Khowaja, PhD candidate at University of British Columbia, was awarded the best student poster at The Canadian Agency for Drugs and Technology in Healthcare (CADTH) symposium that was held on April 10-12, 2016 in Ottawa, Canada. His poster "Understanding Cost Drivers for... Read More
10 May, 2016 Preeclampsia Foundation launched "The Faces of Preeclampsia" campaign for May
The Preeclampsia Foundation has launched an awareness-building campaign called “The Faces of Preeclampsia” in conjunction with May as the National Preeclampsia Awareness Month. Each week the Foundation is highlighting a key issue about pre-eclampsia so that women get the most important messages to ensure a healthy pregnancy.   Topics covered include: Know... Read More
10 May, 2016 Objective 3: GHP Trial Updates (April- May 2016)
The GHP Oral Antihypertensive Trial aims to compare the efficacy of oral labetalol, oral nifedipine, and oral methyldopa for the management of severe hypertension in pregnant women. The study is enrolling at two sites in Nagpur, India: Government Medical College (GMC) and Daga Women’s Hospital. Graph: Enrollment of women in the GHP trial as of April 30, 2016. The study... Read More
6 Apr, 2016 CRADLE launches website
A recent World Health Organisation report states that approximately 800 women die in pregnancy or childbirth every day and 99% of these occur in low and middle-income countries (LMICs). Obstetric haemorrhage, sepsis and pregnancy associated hypertension are the most common causes. Simple and cost-effective interventions are available but delays in recognising maternal... Read More
5 Apr, 2016 CoLab helps publish paper that redefines antenatally-detected fetal growth restriction
  PRE-EMPT is excited to announce that we have published "Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction" in Placenta. This paper demonstrates the capacity of maternal circulating placental growth factor measurement to discriminate between fetuses who are constitutionally-small (normal) and those who are... Read More
31 Mar, 2016 CLIP Nigeria: Experiences from the field
From the CLIP Nigeria Trial there have been many stories from the field where women and their babies have received care from the CLIP intervention. Reports have shown that despite recommendation for urgent referral, sadly, some women are unable to seek care at a higher facility. From the field notes, often these barriers arose from lack of funds for transportation or facility... Read More
30 Mar, 2016 Objective 3: CLIP Trial Updates (February - March 2016)
The CLIP Trial has enrolled 49,722 pregnancies to date including 15,580 pregnancies in India; 28,859 pregnancies in Pakistan; and 5,283 pregnancies in Mozambique. The first of the Feasibility supplement publications (9 articles) is in press and expected very soon in Reproductive Health BMC. The second Feasibility supplement (8 articles) has submitted at the end... Read More
30 Mar, 2016 Sensor Project Update
Last year, The Sensor Project was launched, with the ambition to make potentially lifesaving sensors and smart mobile health applications available and affordable for everyone – everywhere. The inaugural goal of The Sensor Project was to raise $37,500 to supply sensors and training to rural health workers as part of the CLIP Trial. Thanks to our donors, we have achieved... Read More
30 Mar, 2016 The Preeclampsia Foundation Launches a Canadian Site
The Preeclampsia Foundation announces the establishment of Preeclampsia Foundation Canada, a designated affiliate of the Preeclampsia Foundation. The new Canadian affiliate shares the Foundation’s mission to reduce maternal and infant illness, as well as death due to preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Preeclampsia Foundation... Read More
30 Mar, 2016 Objective 1: CAP Study Updates (February - March 2016)
The CAP Study Women with a history of pre-eclampsia in their most recent pregnancy who agree to participate in the study, receive calcium 500mg daily or placebo from enrolment until they become pregnant, and up to 20 weeks of pregnancy. The primary outcome is pre-eclampsia. CAP study progress Since the year-end dip, recruitment has improved. Our plan is to stop... Read More

Pages